These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Repeated percutaneous transluminal septal myocardial ablation leads to reduction of left ventricular outflow-tract pressure gradient in hypertrophic obstructive cardiomyopathy: a case report]. Takeda M; Mori T; Ohashi Y; Ichikawa S; Terashima M; Ejiri J; Awano K J Cardiol; 2006 Jun; 47(6):313-21. PubMed ID: 16800375 [TBL] [Abstract][Full Text] [Related]
52. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Maron BJ; Nishimura RA Circulation; 2014 Oct; 130(18):1617-24. PubMed ID: 25462821 [No Abstract] [Full Text] [Related]
53. Hypertrophic obstructive cardiomyopathy and septal ablation. Steinbis S Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780 [No Abstract] [Full Text] [Related]
54. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. Brown ML; Schaff HV Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):715-22. PubMed ID: 18510487 [TBL] [Abstract][Full Text] [Related]
55. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study. Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612 [TBL] [Abstract][Full Text] [Related]
56. Transcatheter septal ablation in hypertrophic obstructive cardiomyopathy: a technical guide and review of published results. Rigopoulos AG; Sakellaropoulos S; Ali M; Mavrogeni S; Manginas A; Pauschinger M; Noutsias M Heart Fail Rev; 2018 Nov; 23(6):907-917. PubMed ID: 29736811 [TBL] [Abstract][Full Text] [Related]
57. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. Faber L; Ziemssen P; Seggewiss H J Am Soc Echocardiogr; 2000 Dec; 13(12):1074-9. PubMed ID: 11119274 [TBL] [Abstract][Full Text] [Related]
58. Treating hypertrophic cardiomyopathy: two views. Salberg L J Am Coll Cardiol; 2005 Dec; 46(11):2146; author reply 2146-7. PubMed ID: 16325059 [No Abstract] [Full Text] [Related]
59. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729 [TBL] [Abstract][Full Text] [Related]
60. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial? Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]